Quoin Pharmaceuticals Files 8-K
Ticker: QNRX · Form: 8-K · Filed: May 21, 2025 · CIK: 1671502
| Field | Detail |
|---|---|
| Company | Quoin Pharmaceuticals, Ltd. (QNRX) |
| Form Type | 8-K |
| Filed Date | May 21, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, filing, financials
TL;DR
Quoin Pharma filed an 8-K, check for financial updates.
AI Summary
Quoin Pharmaceuticals, Ltd. filed an 8-K on May 21, 2025, reporting other events and financial statements and exhibits as of May 20, 2025. The company, formerly known as Cellect Biotechnology Ltd. and Cellect Biomed Ltd., is incorporated in the State of Israel and has its principal executive offices in Ashburn, VA.
Why It Matters
This filing indicates Quoin Pharmaceuticals is providing updates on its corporate activities and financial status. Investors should review the details for any significant operational or financial changes.
Risk Assessment
Risk Level: low — This is a routine filing for an 8-K, indicating no immediate material adverse events.
Key Players & Entities
- Quoin Pharmaceuticals, Ltd. (company) — Filer
- Cellect Biotechnology Ltd. (company) — Former company name
- Cellect Biomed Ltd. (company) — Former company name
- May 20, 2025 (date) — Date of earliest event reported
- May 21, 2025 (date) — Date of report
FAQ
What specific 'Other Events' are being reported by Quoin Pharmaceuticals, Ltd. in this 8-K filing?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
What is the significance of the 'Financial Statements and Exhibits' being filed?
This suggests that the company is providing updated financial information or relevant exhibits, which could include financial statements or other supporting documents.
When was Quoin Pharmaceuticals, Ltd. previously known by other names?
The company was formerly known as Cellect Biotechnology Ltd. (name change on July 21, 2016) and Cellect Biomed Ltd. (name change on April 6, 2016).
Where are Quoin Pharmaceuticals, Ltd.'s principal executive offices located?
The principal executive offices are located at 42127 Pleasant Forest Court, Ashburn, VA 20148-7349.
What is the SEC file number for Quoin Pharmaceuticals, Ltd.?
The SEC file number for Quoin Pharmaceuticals, Ltd. is 001-37846.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 21, 2025 regarding Quoin Pharmaceuticals, Ltd. (QNRX).